| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701754 | Journal of Thoracic Oncology | 2016 | 33 Pages |
Abstract
The YMR signature has great potential for guiding clinical management for NSCLC, particularly early-stage disease. The signature appears more reproducible than older signatures and functions using a variety of common gene expression platforms.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Wayne PhD, Gaofeng PhD, James R. PhD, Leigh PhD, Robert MD, Shantanu MD,